Back

Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

3 More presentations in this session

Presentation thumbnail
What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.
Professor L. Faber (Bünde, DE)
Abstract Slides
Presentation thumbnail
Is alcohol septal ablation in women performed too late?
Doctor A. Batzner (Wurzburg, DE)
Abstract Slides
Presentation thumbnail
High sensitivity troponin I in hypertrophic cardiomyopathy
Doctor J. Osmanska (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources